These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1978926)
1. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases (2). Feldman M; Burton ME N Engl J Med; 1990 Dec; 323(25):1749-55. PubMed ID: 1978926 [No Abstract] [Full Text] [Related]
2. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases. 1. Feldman M; Burton ME N Engl J Med; 1990 Dec; 323(24):1672-80. PubMed ID: 1978250 [No Abstract] [Full Text] [Related]
3. [Treatment of peptic ulcer with histamine H2-receptor antagonists]. Radbil' OS Sov Med; 1977 Nov; (11):111-9. PubMed ID: 24276 [No Abstract] [Full Text] [Related]
4. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage I-II preparations in the therapy of internal diseases]. Grebnev AL; Miagkova LP; Kkhorshed AM Klin Med (Mosk); 1991 Mar; 69(3):23-7. PubMed ID: 1676772 [No Abstract] [Full Text] [Related]
5. [Therapy of peptic ulcer. H2 receptor blockers]. Domschke W Verh Dtsch Ges Inn Med; 1988; 94():272-5. PubMed ID: 2905101 [No Abstract] [Full Text] [Related]
6. Histamine H2-receptor antagonists. Keithley JK Nurs Clin North Am; 1991 Jun; 26(2):361-73. PubMed ID: 1675461 [TBL] [Abstract][Full Text] [Related]
7. [H2 receptor antagonists in the therapy of peptic ulcer disease]. Dammann HG; Dau B; Dreyer M; Müller P; Simon B Z Gastroenterol; 1987 Aug; 25 Suppl 3():136-45. PubMed ID: 2889298 [TBL] [Abstract][Full Text] [Related]
9. Acid reduction in peptic ulcer disease. Choosing therapy according to drug interactions, individual response, and cost. Parent K Postgrad Med; 1994 Nov; 96(6):53-9. PubMed ID: 7971612 [TBL] [Abstract][Full Text] [Related]
10. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases]. Miagkova LP; Grebenev AL; Kkhorshed AM Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773 [No Abstract] [Full Text] [Related]
11. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease]. Simon B; Müller P; Dammann HG Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962 [TBL] [Abstract][Full Text] [Related]
13. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists]. Hentschel E Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397 [No Abstract] [Full Text] [Related]
14. [Antacids and muscarinic and histamine H2 receptor blockaders in the treatment of peptic ulcer]. Ivashkin VT; Minasian GA Klin Med (Mosk); 1987 Jan; 65(1):24-31. PubMed ID: 2882061 [No Abstract] [Full Text] [Related]
15. [A gastroenterologist's choice: proton pump inhibitors of H2 histamine receptor blockers in the treatment of peptic ulcer]. Morozov IA Klin Med (Mosk); 2001; 79(5):68-71. PubMed ID: 11510196 [No Abstract] [Full Text] [Related]
16. [Antagonists of the histamine H2 receptors in the stomach]. Landa L Gac Med Mex; 1981 Dec; 117(12):472-4. PubMed ID: 6123460 [No Abstract] [Full Text] [Related]
17. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders]. De Natale G; De Natale F; Marino A Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647 [TBL] [Abstract][Full Text] [Related]
18. [What is the role of H2 receptor blockers today in ulcer therapy?]. Creutzfeldt W Internist (Berl); 1996 Sep; 37(9):937-8. PubMed ID: 8964690 [No Abstract] [Full Text] [Related]